Safety of PD-1 Inhibitors in Squamous Non-Small Cell Lung Cancer
2 Tampilan
• 07/14/23
0
0
Menanamkan
administrator
Pelanggan
The panelists, Benjamin Levy, MD; Edward S. Kim, MD, FACP; and Paul K. Paik, MD, identify patients with squamous non-small cell lung cancer who may benefit from immune checkpoint inhibitors and the management of any related toxicity.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru